These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1969685)

  • 21. Sympathetic modulation in practice: the German clinical experience.
    Kupper W; Erlemeier HH; Bleifeld W
    Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
    Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
    Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
    Marlow HF
    Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
    Detry JM; Decoster PM; Buy JJ; Rousseau MF; Brasseur LA
    Am J Cardiol; 1984 Feb; 53(4):439-43. PubMed ID: 6141726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute hemodynamic effects of piroximone i.v. in patients with severe heart failure].
    Scholz M; Kneissl GD; Winkelmann BW; Grohe G; Klittich P; Bussmann WD
    Z Kardiol; 1995 Oct; 84(10):827-33. PubMed ID: 7502570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination therapy in chronic heart failure. Hemodynamic effects with a calcium antagonist-diuretic combination].
    Podszus Th; Peter JH; Völger KD; Zilles P
    Fortschr Med; 1991 Jun; 109(19):403-6. PubMed ID: 1916562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of xamoterol in moderate cardiac insufficiency].
    Kayanakis JG; Larouchi L; Doat P; Grenet B; Fauvel JM; Bounhoure JP
    Presse Med; 1989 Apr; 18(13):667-70. PubMed ID: 2566161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of Corwin (ICI 118,587), a new cardioselective beta-adenoceptor partial agonist.
    Detry JM; Decoster PM; Brasseur LA
    Eur Heart J; 1983 Aug; 4(8):584-91. PubMed ID: 6139282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
    Molajo AO; Bennett DH
    Br Heart J; 1985 Jul; 54(1):17-21. PubMed ID: 2861834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study.
    Tangø M; Lyngborg K; Mehlsen J; Svendsen TL; Trap-Jensen J
    Int J Cardiol; 1992 Jan; 34(1):63-8. PubMed ID: 1347763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective beta-1-adrenoceptor partial agonist treatment for congestive heart failure.
    Shabetai R
    Cardiology; 1990; 77(5):357-66. PubMed ID: 1981492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease.
    Reale A; Nigri A; Gioffrè PA; Motolese M
    Eur J Cardiol; 1979 Feb; 9(2):101-9. PubMed ID: 32041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.
    Colucci WS; Alexander RW; Williams GH; Rude RE; Holman BL; Konstam MA; Wynne J; Mudge GH; Braunwald E
    N Engl J Med; 1981 Jul; 305(4):185-90. PubMed ID: 6113543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic interaction of propranolol and digitalis in patients with arterial hypertension (author's transl)].
    Nechwatal W; König E; Isbary J; Greding H
    Z Kardiol; 1977 Oct; 66(10):572-7. PubMed ID: 919667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
    Vigholt-Sørensen E; Faergeman O; Snow HM
    Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
    Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H; Hanet C; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long-term xamoterol in idiopathic dilated cardiomyopathy.
    Watanabe K; Hirokawa Y; Suzuki K; Masani F; Otsuka H; Shibata A
    Jpn Circ J; 1992 Jan; 56(1):12-20. PubMed ID: 1347090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
    Waller DG; Webster J; Sykes CA; Bhalla KK; Wray R
    Eur Heart J; 1989 Nov; 10(11):1003-10. PubMed ID: 2574108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.